Neurocrine Biosciences Inc (NASDAQ:NBIX)

114.56
Delayed Data
As of Aug 14
 -0.18 / -0.16%
Today’s Change
72.14
Today|||52-Week Range
136.26
+6.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues19.8M15.0M161.6M451.2M
 
 
 
 
 
Cost of Goods Sold----54.0K865.0K
 
 
 
Depreciation And Amortization1.0M1.5M2.4M4.0M
 
 
 
 
 
 
Operating ExpensesGross Income----159.2M446.4M
 
 
 
General Expenses113.0M160.9M290.5M409.5M
 
 
 
 
 
Research And Development81.5M94.3M121.8M160.5M
 
 
 
 
 
Total Operating Expenses114.0M162.4M293.0M414.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-94.2M-147.4M-131.4M36.9M
 
 
 
 
 
Interest Expense On Debt0.000.0019.5M30.5M
 
 
 
Other Expenses3.3M3.4M2.1M700.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.9M-141.1M-142.5M21.8M
 
 
 
 
 
Income Taxes0.000.000.00-730.0K
 
 
Net Income-88.9M-141.1M-142.5M21.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.5M86.7M88.1M90.2M
 
 
 
 
 
Shares To Calculate EPS Diluted84.5M86.7M88.1M95.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.05-$1.63-$1.62$0.22
 
 
 
 
 
EPS Diluted-$1.05-$1.63-$1.62$0.22